Abstract:Mutations in PKD1 (encoding polycystin-1) or PKD2 (encoding polycystin-2) gene cause autosomal dominant polycystic kidney disease (ADPKD), however high levels of polycystins are detected in renal tissues of ADPKD patients. Animal studies showed that loss and gain of function of polycystins are both pathogenic and can induce cystic phenotype in the kidney, which are associated with enhanced renal fibrosis. Recent studies showed that increased expression of polycystins contributes to organ fibrosis. However, the role of polycystins in renal tubulointerstitial fibrosis remains unclear. In this study, we demonstrated that polycystin-1 or polycystin-2 was highly expressed in the kidney of two different fibrotic mouse models and positively correlated with expression of collagen-I. Pharmaceutical inhibition of polycystin-2 with triptolide or genetic knockout of polycystin-2 reduced the expression of epithelial-mesenchymal transition (EMT) markers and deposition of extracellular matrix proteins in fibrotic kidneys. Similarly, conditional knockout of Pkd1 gene also attenuated renal fibrosis in mouse models. Thus, we further hypothesized that inhibition of polycystins delays cyst growth by mitigating renal fibrosis. Here, we showed that polycystin-1 or polycystin-2 was up-regulated in Pkd2 or Pkd1 mice respectively and tightly correlated with the growth of renal cysts and fibrosis development. Genetic deletion of both polycystin-1 and polycystin-2 retarded cyst growth in Pkd1 or Pkd2 mice. Finally, we deleted pkd1 gene in a fibrosis triggered adult ADPKD mouse model at different time point before or after the fibrotic injury. We showed that early and long-term inactivation of Pkd1 delayed fibrosis triggered renal cyst growth in adult Pkd1 mice as compared with mice with late and short-term inactivation of Pkd1 gene. We conclude that tubular obstruction induced polycystin up-regulation is pro-fibrotic and accelerates cyst growth through enhancing renal interstitial fibrosis in ADPKD mice. Our study indicates that ADPKD is caused by both loss and gain function of polycystins. Reduction of the aberrant upregulation of polycystins in cystic kidneys is a therapeutic option for ADPKD patients. ### Competing Interest Statement The authors have declared no competing interest.

Activation of PIEZO1 Inhibits Kidney Cystogenesis

Activation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo

Cyclin-Dependent Kinase 1 Activity is a Driver of Cyst Growth in Polycystic Kidney Disease.

Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model

Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKD

Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies

The Role of PIEZO1 in Urinary Bladder Function and Dysfunction in a Rodent Model of Cyclophosphamide-Induced Cystitis

Inhibiting centrosome clustering reduces cystogenesis and improves kidney function in autosomal dominant polycystic kidney disease

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease

Inositol 1,4,5-Triphosphate Receptor 3 Promotes Renal Cyst Development in Autosomal Dominant Polycystic Kidney Disease

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Cyclic nucleotide signaling in polycystic kidney disease

Cilia to basement membrane signalling is a biomechanical driver of autosomal dominant polycystic kidney disease

EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease

Pkhd1 Gene Silencing May Cause Cell Abnormal Proliferation Through Modulation Of Intracellular Calcium In Autosomal Recessive Polycystic Kidney Disease

Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD

Mechanosensitive Cation Channel Piezo1 Is Involved in Renal Fibrosis Induction

PIEZO1 mediates matrix stiffness-induced tumor progression in kidney renal clear cell carcinoma by activating the Ca2+/Calpain/YAP pathway

cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease

Piezo activity levels need to be tightly regulated to maintain normal morphology and function in pericardial nephrocytes